Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Valneva SE changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 10 | −1 |
| Shares | 653.5K | 717.7K | +64.2K (+9.8%) |
| Value | $4.73M | $4.35M | −$377.3K (−8.0%) |
New holders (1)
Institutions that held Valneva SE at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AlphaMark Advisors, LLC | 150 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Valneva SE at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Qube Research & Technologies Ltd | 22 | $162 |
| Royal Bank of Canada | 18 | $0 |